- Low
- 70,000
- Average
- 70,000
- Median
- 70,000
- High
- 70,000
A.p. Pharma Salary
14
65
31
A.p. Pharma average salary is $70,000, median salary is $70,000 with a salary range from $70,000 to $70,000.
A.p. Pharma salaries are collected from government agencies and companies. Each salary is associated with a real job position. A.p. Pharma salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
A.p. Pharma salaries are collected from government agencies and companies. Each salary is associated with a real job position. A.p. Pharma salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
| Job Title | Salaries | City | Year | More info |
| Lead Quality Assurance Engineer | 70,000-70,000 | Pittsburgh, PA, 15201 | 2013 | A.p. Pharma Lead Quality Assurance Engineer Salaries (1) A.p. Pharma Pittsburgh, PA Salaries |
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
A.p. Pharma salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
A.p. Pharma Jobs
| See more A.p. Pharma Jobs» | |
| Search All Jobs | |
A.p. Pharma... Information
- A.P. Pharma, Inc
- Industry: BioTech/Drugs
- City: Redwood City, CA
- A.P. Pharma, Inc. (NASDAQ NM: APPA) is a specialty pharmaceutical company focused on the development and commercialization of innovative medical treatments utilizing its proprietary polymer-based drug delivery systems.The Company's primary emphasis is on advancing its Biochronomer? technology platform for site-specific and systemic drug delivery. Designed to release drugs over a period of hours, days, weeks or even months, Biochronomer systems can be fabricated into a wide range of solid and gel forms which erode as they deliver the drug. A variety of injectable and implantable applications are undergoing feasibility testing to address major unmet needs in pain management, inflammation, oncology,
